STOCK TITAN
  1. Home
  2. News
  3. ECOR

electroCore to Participate in the JMP Securities MedTech Bio Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.

Event details:

Date: Thursday, October 1, 2020
Time: 2:00pm ET

Audio from the event will be webcast live and available here or on the Investors section of the company’s website.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097


Stock ECOR logo
electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

#4869 Ranked by Market Cap
#411 Ranked by Stock Gains
N/A Ranked by Dividends

ECOR Latest News

May 8, 2024
electroCore Announces First Quarter 2024 Financial Results
May 3, 2024
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
May 1, 2024
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
Apr 30, 2024
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
Apr 8, 2024
electroCore Announces the Launch of Truvaga Plus® for General Wellness

ECOR Stock Data

41.06M
4.17M
18.51%
16.59%
0.17%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
ROCKAWAY

About ECOR

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.